[Ip-health] High cost of new drugs | The BMJ

Els Torreele els.torreele at opensocietyfoundations.org
Thu Aug 18 04:40:09 PDT 2016

You may be interested in this recent BMJ edito on high drug prices by Mariana Mazzucato:

And a response I wrote together with her reacting to critics to her claims of the significant public sector contributions to medical R&D and the poor quality of innovation:

More information about the Ip-health mailing list